|
2010, Volume 56, Issue 1 |
| EXPERIMENTAL/CLINICAL STUDIES |
| 7-25 |
Archakov A.I.
Nanobiotechnologies in medicine: Nanodiagnostics and nanodrugs
|
   |
| 26-39 |
Kaysheva A.L., Ivanov Yu.D., Zgoda V.G., Frantsuzov P.A., Pleshakova T.O., Krohin N.V., Ziborov V.S., Archakov A.I.
Visualization and identification of hepatitis c viral particles by atomic force microscopy combined with ms/ms analysis
|
|
| 40-54 |
Ivanov A.V., Kopylov A.T., Zgoda V.G., Toropygin I.Yu., Khrjapova E.V., Ivanov Yu.D.
Mass-spectrometric identification of interaction sites for cytochrome P450 2b4/nadph cytochrome P450 reductase
|
|
| 55-71 |
Shumyantseva V.V., Suprun E.V., Bulko T.V., Dobrinina O.V., Archakov A.I.
Sensor systems for medical application based on hemoproteins and nanocomposite materials
|
|
| 72-81 |
Rakhmetova S.Yu., Radko S.P., Gnedenko O.V., Bodoev N.V., Ivanov A.S., Archakov A.I.
Photoaptamer heterodimeric constructs as a new approach to enhance the efficiency of formation of photocrosslinking with a target protein
|
|
| 82-89 |
Lisitsa A.V., Shilov B.V., Evdokimov P.A., Gusev S.A.
Knowledgebases in postgenomic molecular biology
|
 |
| 90-100 |
Veselovsky A.V., Sobolev B.N., Zharkova M.S., Archakov A.I.
Computer-based substrate specifity prediction for cytochrome P450
|
|
| 101-119 |
Ipatova O.M., Torkhovskaya T.I., Medvedeva N.V., Prozorovskiy V.N., Ivanova N.D., Shironin A.V., Baranova V.S., Archakov A.I.
Bioavailability of oral drug formulations and methods for its improvement
|
|
| 120-131 |
Belyaeva N.F., Kashirtseva V.N., Medvedeva N.V., Khudoklinova Yu.Yu., Ipatova O.M., Archakov A.I.
Zebrafish as a model system for biomedical studies
|
|
| 132-137 |
Petushkova N.A., Lisitsa A.V., Pozdnev V.F., Karuzina I.I.
Fluorescence-based determination of enzyme activity of recombinant CYP51b1 (sterol 14α-demethylase) with coumarin derivatives
|
|
| SHORT COMMUNICATIONS |
| 138-145 |
Buneeva O.A., Gnedenko O.V., Fedchenko V.I., Ivanov A.S., Medvedev A.E.
Interaction of human cytokeratins with isatin analogues
|
|